Science
Mechanism of Action
Methoxycinnamal functions as a selective chemical sunscreen by absorbing ultraviolet B (UVB) radiation, with peak efficacy around 310-311 nm. Upon absorption, it converts the high-energy UVB light into thermal energy, which is then safely dissipated, effectively preventing UVB-induced cellular damage and sunburn. It does not provide protection against longer-wavelength UVA radiation.
Research
Clinical Evidence
High confidence7.5%
Key findings
- 01 Clinical data recommends a concentration range of 0.5% to 7.5% for effective UVB protection.
- 02 The FDA approves its use in sunscreens at concentrations up to 7.5%.
- 03 A 7.5% concentration has been shown to reduce insolation four-fold.
- 04 The EU permits its use in sunscreens up to 10% concentration, aligning with the CIR expert panel's safety assessment for cosmetics up to 10%.
Transparency
Dusting Analysis
Recent FDA studies demonstrate rapid transdermal absorption of Methoxycinnamal, leading to plasma concentrations (peak 5.5 ng/mL) significantly above the 0.5 ng/mL safety threshold after a single application, indicating systemic exposure. This, coupled with the European Commission's SCCS inability to conclude on safety due to genotoxicity concerns and confirmed endocrine-active properties, necessitates careful consideration for precision formulations.
The Formula
Formulation
Stability
Methoxycinnamal is stable at ambient conditions but is light-sensitive; it can photodegrade upon sun exposure, potentially losing up to 10% of its SPF protection within 35 minutes. It is insoluble in water but readily dissolves in oils and organic solvents. To enhance stability and achieve broad-spectrum protection, it is often co-formulated with other UV filters.
Synergies
- Often combined with zinc oxide, titanium dioxide, or avobenzone to enhance stability and achieve broad-spectrum UV protection.
Conflicts
- Benzoyl Peroxide (oxidative properties can degrade Methoxycinnamal, reducing effectiveness and potentially causing skin irritation).
- Low pH Vitamin C (Ascorbic Acid) (low pH environment can destabilize Methoxycinnamal, making it less effective and potentially leading to increased skin irritation).
- Powders like titanium oxide and/or zinc oxide (can potentially increase irritation by Octylmethoxycinnamat when mixed in amounts of 10% or less in external skin preparations).
Safety
Safety Profile
While the CIR expert panel concluded Methoxycinnamal is safe for use in cosmetics at concentrations up to 10%, the European Commission's SCCS issued a preliminary opinion in November 2024, stating insufficient data to exclude genotoxicity and confirming endocrine-active properties (estrogenic and weak anti-androgenic). FDA studies reveal rapid skin absorption, exceeding the 0.5 ng/mL safety threshold, with detection in human urine, blood, and breast milk. It may cause allergic contact dermatitis or photo contact dermatitis in some individuals. Environmentally, it is not considered reef-safe and has been banned in regions like Hawaii and Key West due to harmful effects on marine ecosystems.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its efficacy as a UVB filter, Methoxycinnamal's systemic absorption, confirmed endocrine-disrupting properties, unresolved genotoxicity concerns by the SCCS, and negative environmental impact make it an unsuitable ingredient for Moumoujus's precision formulations.
Related
Similar Ingredients
Finding similar ingredients…